Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05766475 · ClinicalTrials.gov registry record · NA

In-person vs. Virtual Delivery of a Group-based Prevention of Postpartum Depression

A NA study of Postpartum Depression, sponsored by University of Denver.

Recruiting
Registry status
NA
Development phase
900
Enrollment target
1
Study location

NCT05766475: Recruiting NA study of Postpartum Depression, sponsored by University of Denver.

NCT05766475 is a NA study of Postpartum Depression that is actively recruiting participants, run by University of Denver. The registered enrollment target is 900 participants, above the 456-participant average among 47 other Postpartum Depression trials with a reported enrollment target (97% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05766475, a NA study of Postpartum Depression, is actively recruiting participants, sponsored by University of Denver.

RECRUITING
Registry status
NA
Development phase
900 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to test whether an established preventive intervention (group interpersonal therapy) delivered virtually shows the same benefits for preventing postpartum depression as it does when delivered in person.

Primary Outcome

Self reported depression scores. Possible range of scores is 0 to 80, with the higher scores indicating higher depression levels.

Conditions Studied

Interventions

  • BEHAVIORAL ROSE Program: In Person
  • BEHAVIORAL ROSE Program: Virtual

Study Locations (1)

Colorado

  • Denver Health Medical Center - Denver

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2023-03-13
Est. Completion 2027-06
Phase NA
University of Denver

13 total trials

What NCT05766475 shows while recruiting

NCT05766475 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, above the 456-participant average among 47 other Postpartum Depression trials with a reported enrollment target (97% higher).

The record links to 1 condition, with Postpartum Depression appearing as the primary indexed condition, and to 2 interventions - of which ROSE Program: In Person is the first listed.

NCT05766475 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT05766475 about?

NCT05766475 is a clinical study titled "In-person vs. Virtual Delivery of a Group-based Prevention of Postpartum Depression". The goal of this clinical trial is to test whether an established preventive intervention (group interpersonal therapy) delivered virtually shows the same benefits for preventing postpartum depression as it does when delivered in person.

What is the current status of trial NCT05766475?

This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2023-03-13. Estimated completion is 2027-06.

What conditions does trial NCT05766475 study?

This clinical trial studies the following conditions: Postpartum Depression.

What interventions are being tested in trial NCT05766475?

The interventions under investigation include: ROSE Program: In Person (BEHAVIORAL), ROSE Program: Virtual (BEHAVIORAL).

Who is sponsoring clinical trial NCT05766475?

This trial is sponsored by University of Denver, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05766475 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postpartum Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05766475's enrollment target sits among peer trials

900 3rd of 47 higher than 45 of 47 other Postpartum Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Postpartum Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02352116 · 900 participants · NA

    Evaluation of Post-PACU Pain Management in Pediatric Surgery

  • NCT02414347 · 900 participants

    F 18 T807 Tau PET Imaging of Alzheimer's Disease

  • NCT02670408 · 900 participants

    Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

  • NCT02960022 · 900 participants · Phase 2

    A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05766475, the US trial registry maintained by the National Library of Medicine. NCT05766475 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.